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Abstract: The upper gastrointestinal (GI) tract plays a critical role in sensing the arrival of a meal,
including its volume as well as nutrient and non-nutrient contents. The presence of the meal in the
stomach generates a mechanical distension signal, and, as gastric emptying progresses, nutrients
increasingly interact with receptors on enteroendocrine cells, triggering the release of gut hormones,
with lipid and protein being particularly potent. Collectively, these signals are transmitted to the
brain to regulate appetite and energy intake, or in a feedback loop relayed back to the upper GI
tract to further adjust GI functions, including gastric emptying. The research in this area to date has
provided important insights into how sensing of intraluminal meal-related stimuli acutely regulates
appetite and energy intake in humans. However, disturbances in the detection of these stimuli have
been described in a number of eating-related disorders. This paper will review the GI sensing of
meal-related stimuli and the relationship with appetite and energy intake, and examine changes in GI
responses to luminal stimuli in obesity, functional dyspepsia and anorexia of ageing, as examples
of eating-related disorders. A much better understanding of the mechanisms underlying these
dysregulations is still required to assist in the development of effective management and treatment
strategies in the future.
Keywords: gastrointestinal sensing; nutrients; gastric distension; impaired gastrointestinal function;
obesity; functional dyspepsia; anorexia of ageing
1. Introduction
Meal ingestion is associated with well-established changes in upper gastrointestinal (GI) functions
that serve to accommodate food in the stomach and break it down to particles of appropriate size
for transfer into the small intestine for digestion and subsequent absorption. During these processes,
the presence of food in the GI lumen generates a variety of signals arising from gastric distension,
nutrient and non-nutrient compounds contained in the food, as well as gut hormones released from
enteroendocrine cells in the gut wall [1–4]. Distension of the stomach, induced by the volume of food
ingested, activates mechano-sensitive vagal afferent fibres with nerve endings in the submucosa and
smooth muscle layers of the gastric wall [5–7], and gives rise to a sensation of fullness [8]. As gastric
emptying progresses, the inputs from mechanical distension diminish gradually, while the small
intestinal lumen is increasingly exposed to nutrients, including fats, proteins, carbohydrates and
their digestion products. These are detected, or ‘sensed’, by highly specialised receptors, primarily G
protein-coupled receptors, located on the luminal side of enteroendocrine cells, triggering a cascade of
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intracellular events to increase intracellular calcium, and culminating in the release of gut hormones
from the basolateral side [2,3,9]. Gut hormones, e.g. cholecystokinin (CCK) and glucagon-like peptide-1
(GLP-1), then activate receptors located on adjacent endings of submucosal vagal afferent, as well as
enteric, neurons. This information, together with the signals from gastric distension, is transmitted to the
brainstem, and from there to higher centres, including the hypothalamus, to modulate eating behaviour.
Within the brainstem, signals are also relayed from the nucleus of the solitary tract to the dorsal motor
nucleus of the vagus, from which vagal efferents trigger feedback regulation of GI motor functions,
including stimulation of pyloric pressures, leading to the slowing of gastric emptying [2,4,6,10].
Following their release from enteroendocrine cells, gut hormones are also transported in the blood
stream to peripheral organs, including the stomach, where they activate specific receptors expressed
on smooth muscle cells and enteric neurons, e.g., in the pylorus, to modulate gastropyloroduodenal
motility associated with slowing of gastric emptying (Figure 1). Because the molecular and cellular
processes involved in the sensing of these GI luminal signals cannot be investigated readily in humans,
the changes in circulating concentrations of gut hormones, as well as effects on GI motor functions,
including modulations in GI motility and slowing of gastric emptying, in response to these signals are
frequently evaluated as ‘markers’ of GI luminal sensing in clinical studies.
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Figure 1. Schematic representation of the gastrointestinal (GI) sensing of meal-related stimuli, and 
effects on GI functions (specifically gut hormone release and slowing of gastric emptying), appetite 
and energy intake. Meal ingestion initially induces gastric distension, which activates 
mechanoreceptors on vagal afferents that terminate in the gastric wall and transmit this signal to the 
central nervous system (1). As chyme enters the small intestine in the process of gastric emptying, 
nutrients are sensed by receptors located on enteroendocrine cells, triggering GI hormone secretion 
(2). GI hormones convey meal-related information to the brain involving various pathways, including 
activation of hormone-specific receptors on vagal afferent endings (3) or following transport through 
the blood stream (4). Together, these inputs are conveyed to higher brain centres to modulate eating 
behaviour, appetite and energy intake (5), as well as feedback regulation of GI motor functions, 
particularly pyloric pressures, associated with the slowing of gastric emptying (6). The latter can also 
occur through endocrine pathways (7). 
While the processes outlined above underlie the regulation of normal GI function, appetite and 
energy intake, dysregulations can occur in a range of disorders which adversely affect eating, or lead 



















Figure 1. Schematic representation of the gastrointestinal (GI) sensing of meal-related stimuli, and
effects on GI functions (specifically gut hormone release and slowing of gastric emptying), appetite and
energy intake. Meal ingestion initially induces gastric distension, which activates mechanoreceptors
on vagal afferents that terminate in the gastric wall and transmit this signal to the central nervous
system (1). As chyme enters the small intestine in the process of gastric emptying, nutrients are sensed
by receptors located on enteroendocrine cells, triggering GI hormone secretion (2). GI hormones
convey meal-related information to the brain involving various pathways, including activation of
hormone-specific receptors on vagal afferent endings (3) or following transport through the blood
stream (4). Together, these inputs are conveyed to higher brain centres to modulate eating behaviour,
appetite and energy intake (5), as well as feedback regulation of GI motor functions, particularly
pyloric pressures, associated with the slowing of gastric emptying (6). The latter can also occur through
endocrine pathways (7).
While the processes outlined above underlie the regulation of normal GI function, appetite and
energy intake, dysregulations can occur in a range of disorders which adversely affect eating, or lead to
GI symptoms, including exaggerated postprandial fullness, nausea and bloating [11–14]. For example,
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in obesity, GI sensitivity to dietary fat appears to be decreased, possibly as a consequence of excess
energy intake [15]. Psychiatric eating disorders, including anorexia nervosa and bulimia nervosa,
have been found to be associated with an enhanced sensitivity to gastric distension and alterations
in GI hormone secretion in response to nutrients [16,17]. GI disorders (including gastro-oesophageal
reflux disease, and the functional GI disorders, functional dyspepsia and irritable bowel syndrome),
have in common a hypersensitivity to luminal stimuli, particularly fat, triggering postprandial GI
symptoms [18]. Critical illness (including sepsis, trauma, burns, head injuries or surgical emergencies
in patients admitted to an intensive care unit) is also associated with hypersensitivity to small intestinal
nutrients and GI motor dysfunctions, resulting in intolerance of gastric feeding [12,19]. Finally, ageing,
while characterised by a reduced GI sensitivity to both fat and protein, has also been found to be
associated with a range of changes in GI functions, including gastric emptying and hormone release [20],
which may contribute to the characteristic loss of appetite, termed ‘anorexia of ageing’.
This review will provide a brief overview of the GI sensing of meal-related signals in humans,
specifically, gastric distension and small intestinal nutrients, thus focusing on preabsorptive signals, by
describing their effects on GI functions, appetite and energy intake. We will also examine dysregulations
in the GI responses to these signals. While, as described above, these can occur in a wide range of
disorders, a comprehensive review is beyond the scope of this paper. Thus, we will illustrate key
changes, and their functional implications, using obesity, functional dyspepsia and anorexia of ageing
as examples. With regards to nutrients, we will focus on fat and protein because their GI sensing is
primarily altered in these disorders, as alluded to above. Thus, while carbohydrates are, of course, also
sensed in the intestinal lumen [21], a discussion of their effects is beyond the scope of this paper.
2. GI Sensing of Intraluminal Meal-Related Stimuli
The arrival of a meal in the upper GI tract in the process of food ingestion exerts powerful signals,
including gastric distension as a result of the meal volume, as well as the chemical components of
the meal, particularly macronutrients, that modulate postprandial GI functions, including gastric
emptying, GI motility and the release of GI hormones, associated with changes in appetite perceptions
and subsequent energy intake. As outlined above, while the investigation of GI sensing of intraluminal
stimuli at the receptor level is currently not feasible in human studies in-vivo, the measurement of
the downstream manifestations, including changes in upper GI motility, gut hormone release, as well
as appetite perceptions and energy intake, provides a relatively non-invasive means to quantify the
ability to ‘sense’ these stimuli in the GI lumen in clinical research.
2.1. Sensing of Gastric Distension
Meal ingestion induces a gradual distension of the gastric wall, inducing fullness and acting as
a first signal to control meal size [8,22–24]. For example, experimental distension of the proximal
stomach using a bag attached to a gastric barostat gradually increases the perception of fullness,
as the distension, induced either by increasing volume or pressure within the bag, increases [8,23].
Gastric distension before, or during, meal ingestion also reduces subsequent food intake [24]. Filling
of the antrum also plays a role in the perception of fullness and meal termination [25]. For example,
studies using scintigraphy or ultrasound to quantify intragastric volume and meal distribution showed
that fullness after consumption of a 350-mL glucose drink was directly related to the volume in the
distal stomach [25]. Moreover, suppression of energy intake after a mixed-nutrient drink was related
inversely to antral area (a measure of antral filling) immediately before the meal [26]. The relative
importance of the proximal vs distal stomach cannot be determined from these studies. However,
because a meal is initially stored primarily in the proximal stomach (as a result of proximal gastric
relaxation) and, in the process of gastric emptying, gradually transferred into the antrum prior to
evacuation into the small intestine, it is likely that the relative importance of the two regions changes
as a result of changes in the intragastric distribution of the meal as gastric emptying progresses.
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2.2. Effects of Nutrients in the Small Intestinal Lumen
As gastric emptying progresses and the signal from gastric distension diminishes, chyme enters
the small intestinal lumen in a tightly regulated fashion. This is achieved by well-characterised effects
of nutrients on pressures in the antropyloroduodenal region [27], mediated by gut hormones released
in response to nutrients [2,3,10]. Nutrients in the intestinal lumen, particularly lipid and protein,
also modulate appetite and subsequent energy intake [28,29], and changes in both motility and gut
hormones play critical roles [30,31].
2.2.1. Small Intestinal Sensing of Lipid
The presence of lipid in the GI lumen provides a potent signal to stimulate the GI functions that
are key to the regulation of appetite and energy intake [15]. For example, infusion of lipid, at loads
of 1–4 kcal/min, directly into the duodenum, to exclude any sensory inputs from the oral cavity or
confounding effects of variations in the rate of gastric emptying, induces well-coordinated changes
in upper GI motility, including the stimulation of pyloric pressures [28], which underlie the slowing
of gastric emptying [27]. Lipid also stimulates the release of GI hormones, including CCK, GLP-1
and peptide YY (PYY), while the release of ghrelin from the stomach is suppressed [10]. These effects
occur in a load-dependent manner, and are associated with the suppression of energy intake [28,32].
In fact, the magnitude of the stimulation of pyloric pressures and plasma CCK, as indicators of the GI
sensing of nutrients, have been identified as independent determinants of energy intake in response to
intraduodenal administration of particularly fat and also protein [30,31].
The above-mentioned effects of fat on GI functions, including gastric emptying, GI motility, gut
hormone release and energy intake, are abolished by co-administration of the lipase inhibitor, orlistat,
establishing that the GI effects of fat are dependent on fat digestion, and lipid digestion products,
namely fatty acids, are essential for intestinal lipid sensing [33,34]. Thus, the digestibility of fat affects
its sensing in the GI lumen. Once fatty acids are released in the process of lipid digestion, their effects
on GI functions are chain-length dependent [35]. Moreover, even within the group of fatty acids with
≥12 carbon atoms, fatty acids appear to have different potencies [36,37]. For example, only lauric
acid (C12), but not oleic acid (C18:1), reduced subsequent energy intake when infused at a load of
0.4 kcal/min [36], while C18:1 was effective at the higher load of ~0.75 kcal/min [37], suggesting that
the threshold loads required for luminal detection differ between fatty acids. The sensing of fatty acids
in the GI lumen [38,39] is associated with the release of GI hormones, including CCK and GLP-1 [2,3],
which are involved in transmitting nutrient-related information to the brain, and, in case of CCK, at
least in part, via CCK-A receptor-dependent mechanisms [40,41].
2.2.2. Small Intestinal Sensing of Protein
Dietary protein has been recognised to have potent effects to modulate GI functions and suppress
appetite and food intake [42,43]. Amongst proteins, whey protein appears to be particularly potent [44].
For example, intraduodenal administration of whey protein, at loads of 0.5–3 kcal/min, stimulates
pyloric pressures and modulates the release of gut hormones, including stimulation of CCK, GLP-1
and PYY, and suppression of ghrelin, and reduces subsequent energy intake, in a dose-dependent
manner [29,45]. Moreover, the effects of whey protein, which is digested relatively rapidly, on GI
hormone release, slowing of gastric emptying and suppression of energy intake are greater than those
of casein, which coagulates in the stomach, suggesting a role for the digestibility of proteins in its
sensing in the GI lumen [46]. Thus, as with lipids and fatty acids, amino acids may mediate, at least in
part, the effects of protein on GI functions and energy intake [47–49]. There has, therefore, been an
increased interest in evaluating the effects of specific amino acids on these outcomes [49,50]. However,
the assessment of the effects of amino acids is complicated by the number of amino acids at play,
their varying structures, their inter-dependence (e.g., for effective absorption) and the large range of
their effects outside the GI tract. Nevertheless, a number of amino acids, when given in relatively
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small amounts, modulate gut functions and reduce energy intake [51–55]. For example, L-tryptophan,
given orally, intragastrically or intraduodenally, stimulates plasma CCK and pyloric pressures, slows
gastric emptying and suppresses energy intake in healthy, lean individuals [52,54,55]. In addition,
the suppression of energy intake by amino acids, e.g., L-tryptophan and L-leucine, is also related to
the circulating concentrations of these amino acids [51,52], in line with the recognition that the effects
of amino acids on energy intake are also regulated by extraintestinal factors, which may act in the
periphery and/or the brain [56]. This may explain, at least in part, why intraduodenal protein and lipid
infusions have comparable effects to suppress subsequent energy intake, despite protein stimulating
gut hormones and pyloric motility much less than lipid [32].
Taken together, the sensing of both lipid and protein, through their digestion products, has potent
effects on GI functions, associated with a reduction in appetite and energy intake. While much work
has been done in this area in humans, understanding the molecular processes involved in GI sensing
still relies largely on preclinical studies, or ex-vivo investigations of clinical samples (e.g., human
biopsies). Thus, technical advances are required that will enable in-vivo studies of these processes in
healthy humans as well as relevant patient populations. A thorough understanding of the mechanisms
underlying these processes is critical for a better understanding of the dysregulations in GI sensing
underlying eating-related disorders, to develop effective management and treatment strategies.
3. Altered GI Sensing of Meal-Related Stimuli in Eating-Related Disorders
While, as discussed, luminal meal-related stimuli contribute to the regulation of GI functions,
appetite and energy intake, disturbances in the sensing of these stimuli have been found in a number
of eating-related disorders, including a reduced intestinal sensitivity to the GI effects of fat in obesity,
associated with dietary overconsumption [57], an exaggerated sensitivity to both gastric distension
and intestinal lipid in patients with functional dyspepsia, associated with digestive symptoms [18],
and reduced GI sensory perception associated with a loss of appetite with ageing [20] (Table 1).
Table 1. Changes in upper GI luminal sensing that have been described in eating-related disorders.
GI Sensory Disturbances References
Obesity
↓ Sensitivity to gastric distension
↑ Gastric capacity
↓ Sensitivity to small intestinal lipid
?↓ Sensitivity to CCK, PYY, ghrelin
↑ ↓ ↔ CCK secretion




↑ Sensitivity to gastric distension
↑ Sensitivity to small intestinal nutrients
↑ ↔ CCK secretion
?↑ Sensitivity to CCK
↑ Ghrelin, PYY secretion
↓ Gastric emptying




↑ Sensitivity to gastric distension
↑ Gastric capacity
↓ CCK secretion
↓ ↔ Gastric emptying
↓ Proximal gastric accommodation
[16,17,68]
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Table 1. Cont.
GI Sensory Disturbances References
GI disorders
Gastroesophagealreflux disease
↑ Sensitivity to gastric distension





↑ Sensitivity to gastric distension
↑ Sensitivity to small intestinal lipid






↑ Sensitivity to gastric distension
↑ Sensitivity to small intestinal lipid
↓ Gastric emptying
↑ ↓ Gut motility
[18,84,85]
Critical illness
↓ Sensitivity to gastric distension
↑ Sensitivity to small intestinal nutrients
↑ CCK, PYY secretion




↓ Sensitivity to gastric distension
↓ Sensitivity to small intestinal nutrients
↑ CCK secretion
↑ ↓ ↔ PYY, GLP-1 and ghrelin secretion
?↓ Sensitivity to CCK, PYY and GLP-1
↓ ↔ Gastric emptying
↑ Proximal gastric retention
[26,87–102]
↑, increase; ↓, decrease;↔, unchanged; ?, uncertain; GI, gastrointestinal; CCK, cholecystokinin; PYY, peptide YY;
GLP-1, glucagon-like peptide-1.
3.1. Altered GI Sensing in Obesity
People with obesity, as a group, consume larger amounts of food, and have a preference
for particularly high-fat and energy-dense foods; thus, it is conceivable that their ability to sense
meal-related stimuli (e.g., distension of the stomach, dietary fat) in the GI lumen is compromised.
3.1.1. Sensitivity to Gastric Distension
Obese individuals have been found to have greater fasting gastric volumes [58], and in most, but
not all, studies tolerate greater intragastric volumes, as measured by gradually filling a bag positioned
in the stomach with air or water [59–61], or consume larger amounts of water or nutrient loads during
drink challenges [58]. Thus, obese individuals appear to be less sensitive to gastric distension and
require larger intragastric volumes to experience fullness. While data relating to gastric meal emptying
in obese have been inconsistent (with studies reporting slower or faster emptying, or no differences
from lean individuals [62]), possibly in part due to differences in study design and methodological
approaches [15], a comprehensive recent study of 328 participants found that gastric emptying of
both solid and liquid components of a mixed meal was accelerated in obese subjects [58]. Accelerated
gastric emptying is associated with an enhanced exposure of the small intestine to nutrients, which
has been shown to induce structural changes in the mucosa and facilitate nutrient absorption [103],
therefore, differences in GI functions and energy intake in response to nutrients may be the result of
reduced feedback from small intestinal nutrients, particularly fat.
3.1.2. Small Intestinal Sensing of Fat
Experimental evidence that the overconsumption of energy-dense, high-fat foods is associated
with a reduced GI sensitivity to fat has been derived mainly from short-term overfeeding studies,
Nutrients 2019, 11, 1298 7 of 19
often conducted in normal-weight people [104–107]. For example, in normal-weight individuals,
consumption of a high-fat diet for 2 weeks accelerated gastric emptying of a high-fat meal [104],
and attenuated the pyloric motor response to an intraduodenal lipid infusion, when compared with
the low-fat diet [107]. The effect on gastric emptying was fat-specific, since gastric emptying of a
high-carbohydrate meal was not accelerated after the high-fat diet [104]. There is, indeed, also evidence
that obese people are less sensitive to the appetite-suppressant effects of dietary fat [42,43,63,64]. For
example, obese volunteers consumed a greater amount of food from a high-fat meal than healthy
controls [63], and, unlike healthy controls, obese participants did not reduce subsequent energy intake
after a high-fat meal [42]. Only few studies have specifically evaluated the gut hormone responses to
fat ingestion in obese people, and findings are somewhat conflicting. For example, male and female
obese volunteers were reported to have a greater plasma CCK response to a soup containing 30 g of
margarine than healthy controls, despite comparable gastric emptying in the two groups [65], although
gastric emptying of fat was not specifically quantified, and thus, may have been faster, potentially
resulting in greater CCK stimulation. In contrast, we found no differences in plasma CCK between
obese and lean male adults during 3 h after ingestion of a solid high-fat meal [42]. Solid meal emptying
is slower than liquid emptying, possibly explaining the differences between the outcomes in the
two studies; however, the latter study did not evaluate gastric emptying. Finally, we have reported
reduced plasma CCK concentrations during 90-min intraduodenal administration of oleic acid in obese,
compared with lean, men [66], indicating that the small intestinal response to a standardised fatty acid
load is reduced in obese people, most likely due to compromised small intestinal lipid sensing. While
PYY concentrations following consumption of a high-fat meal have been reported to be lower in obese
than lean individuals [43], PYY and ghrelin responses to a high-fat meal have also been found to be
comparable in the two groups [42]. Taken together, the limited available data suggest that obesity
may be associated with a reduced ability to sense dietary fat, which may compromise the initiation
of appropriate feedback mechanisms, including gut hormone responses. Fat-induced gut hormone
secretion may be reduced, or, in the case of normal secretion, the sensitivity to hormones may be
compromised, and these changes may contribute to altered energy intake regulation.
There is also limited evidence that dietary restriction can, at least in part, improve intestinal
responses to intraluminal fat in obesity [108,109], further supporting a contributory role of diet.
For example, in obese volunteers, dietary restriction for 4 days (~1000 kcal/day) significantly enhanced
plasma PYY, ghrelin suppression and pyloric contractions in response to intraduodenal lipid, associated
with suppression of energy intake [108]. Moreover, 30% dietary restriction for 12 weeks was associated
with greater intraduodenal lipid-induced stimulation of PYY and basal pyloric pressures, and reduced
energy intake [109].
3.1.3. Small Intestinal Sensing of Protein
In contrast to lipids, obese people appear to remain sensitive to the GI and appetite-suppressant
effects of protein, also evidenced by the potent effects of high-protein diets to achieve weight
loss [110,111]. For example, energy intake 3 h after a high-protein meal was lower than after a
high-carbohydrate control meal, while (as discussed above), a high-fat meal did not reduce subsequent
intake [42]. Similarly, a high-protein meal reduced hunger perceptions for 3 h post-meal substantially
more than a high-fat meal, and the response to protein did not differ from those in lean participants [43].
These effects of protein may be mediated, at least in part, by gut hormones; however, current evidence
is limited and inconsistent. For example, the potent suppression of hunger by the high-protein meal
was accompanied by marked stimulation of plasma PYY, although absolute concentrations were lower
in the obese than in the lean group, while no differences in plasma GLP-1 or ghrelin concentrations
were observed between groups [43]. In contrast, in the other study [42], the high-protein meal led to
sustained CCK stimulation and ghrelin suppression in both lean and obese, while the PYY response
did not differ between the high-protein and high-fat meal in lean or obese. Nevertheless, that these
responses are, at least in part, mediated from the small intestine, is supported by a recent study [112]
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in which the antropyloroduodenal pressure, plasma CCK and GLP-1 responses to intraduodenal whey
protein, at the load of 3-kcal/min, did not differ between lean and obese subjects, although energy
intake was non-significantly higher in the obese.
The role of specific amino acids in the responses to protein is currently unclear, with limited
information on the comparative effects of amino acids on GI functions and energy intake in health and
obesity. Intraduodenal infusion of tryptophan had comparable effects on pyloroduodenal motility
in lean and overweight participants [113], and intragastrically administered tryptophan slowed
gastric emptying and reduced energy intake after a mixed-nutrient drink in ~50% of lean and obese
individuals [114]. In contrast, obese individuals have been reported to be less able to detect glutamate
orally [115], suggesting that obese individuals may be less sensitive to palatable umami taste, which
may contribute to higher food intakes.
Taken together, obese people appear to be less sensitive to gastric distension, and the GI and
appetite-suppressant effects of fat, possibly as a result of overconsumption of high-fat, energy-dense
diets, while the responses to protein remain relatively intact. Further research is needed to elucidate
the mechanisms that underlie these changes, and the differential responses to protein and fat, as well as
the responses to dietary restriction, at the level of the receptors, and along the pathways that transmit
the information to the brain, to develop novel, and effective, strategies to better manage or treat, and
ideally prevent, obesity.
3.2. Altered GI Sensing in Functional Dyspepsia
Functional dyspepsia (FD) is a multi-factorial disorder characterised by symptoms, including
nausea, fullness, discomfort, bloating and vomiting, originating in the upper GI region, often triggered
in close temporal association with meal ingestion, with patients unable to complete normal-sized
meals [11,116]. This originally led to the assumption that FD was due to abnormalities in GI motor
activity and gastric emptying; however, correlations between symptoms and changes in these functions
are not strong. A number of contributing factors and mechanisms have been identified in FD, including
gastroduodenal inflammation and changes in the epithelial barrier, GI infections, gut microbiota,
genetic contributions, cognitive and psychological factors [73,117], and a key feature is an increased GI
sensitivity to meal-related stimuli, including gastric distension (potentially exacerbated by delayed
gastric emptying, impaired proximal stomach accommodation, abnormal intragastric meal distribution
and disordered antroduodenal motor function) and/or small intestinal nutrients [73].
3.2.1. Sensitivity to Gastric Distension
The frequent occurrence of FD symptoms in close temporal association with meal ingestion [74,118]
suggested an enhanced sensitivity to distension of the stomach by the meal volume. Indeed, studies
evaluating the gastric sensory response to gastric distension have revealed that 30–48% of patients
exhibit a hypersensitivity to mechanical distension of the stomach [75,76]. Thus, when either the
proximal [75,76] or distal [77] stomach was distended with an air-filled bag, FD patients reported
both perception and discomfort at lower distension volumes or pressures than healthy controls.
This hypersensitivity to gastric distension is also likely to underlie the inability of FD patients to
complete normal-sized meals.
3.2.2. Alterations in the Small Intestinal Sensing of Nutrients
The frequent complaints by FD patients that certain foods or meals induce, or exacerbate, their
symptoms suggest that FD might also be associated with a hypersensitivity to specific nutrients or
other food components. Since rich and fatty foods appear to be particularly potent in triggering
dyspeptic symptoms [11,73], a body of research has investigated a specific hypersensitivity to fat.
However, a range of other foods, or food groups, are also frequently reported by patients to lead to
symptoms [73,119–122], including milk and dairy products, meat, carbohydrate- or wheat-containing
foods or drinks, certain vegetables (possible particularly those vegetables containing fermentable
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oligo-, di- and mono-saccharides and polyols, or ‘FODMAPs’ [123]), sour, acid-secreting or irritant
foods, including citrus fruit, spices, coffee and alcohol [120,121,124]. Thus, in addition to an enhanced
fat sensitivity, hypersensitivities to other nutrients or food components may also exist.
Hypersensitivity to lipid: Approximately 60–70% of FD patients display a hypersensitivity to
fat [72,78–80]. For example, dyspeptic symptoms, including epigastric pain, bloating and nausea,
were substantially greater in response to a high-fat soup than a bland soup [80]. Similarly, a palatable
high-fat yogurt was associated with significantly greater fullness, nausea and bloating than an
equivolaemic fat-free yogurt [78,79]. The importance of a contribution from the small intestine is
highlighted by the fact that intraduodenal infusion of a long-chain triglyceride emulsion induced
typical symptoms, and exacerbated the sensitivity to gastric distension, in patients, but not healthy
controls [72]. This hypersensitivity appears to be fat-specific, since infusion of glucose did not induce
symptoms [81]. Moreover, administration of the CCK-A receptor antagonist, dexloxiglumide, reduced
nausea, bloating and fullness, induced by duodenal lipid infusion, in patients [82], providing evidence
that CCK mediates, at least in part, the effects of fat on symptoms in FD. Whether FD is associated
with a hypersensitivity to [82,83], or altered secretion of [79], CCK, or both, and the involvement of
other gut hormones, remains unclear and warrants investigation.
Responses to other nutrients: Since protein, similarly to fat, potently affects upper GI functions
and energy intake in healthy people, it is conceivable that protein consumption could also generate
FD symptoms; however, this has not been investigated. One study quantifying eating habits and the
temporal relationship with dyspeptic symptoms in FD over one week indicated that although there was
no difference in dietary protein consumption between FD and healthy individuals, postprandial fullness
was related to protein in the patients [74]. Moreover, some patients report dyspeptic symptoms after
consumption of wheat-containing foods [119,120,125], which may be related to gluten [126,127], and a
gluten-free diet has been found to reduce dyspeptic symptoms [127]. However, it is not clear whether
such findings relate specifically to an intolerance of gluten or, more broadly, to other protein sources.
Findings relating to effects of different sources of carbohydrate on FD symptoms are limited.
One study reported inverse relationships between overall symptoms and fullness with carbohydrate
intake [74], suggesting that carbohydrates overall play a favourable role. The role of dietary fibre in FD
is still uncertain [120,128]. No studies have evaluated the role of FODMAPs, or their elimination from
the diet, in FD. Symptoms reported in response to milk ingestion may be due to lactose intolerance, or
relate to the fat or protein content of milk, but this requires further study [120].
Taken together, FD is associated with hypersensitivities to both gastric distension and small
intestinal nutrients, particularly fat; thus, these disturbances may, at least in part, address the patients’
frequent complaints of an inability to complete normal-sized meals and intolerance of fatty foods.
Much more research is required to clarify the contributions of a large range of other foods, and food
components, including protein, to FD symptoms, and mechanisms involved, ideally in large studies
to allow sub-grouping of patients. Such approaches are vital, as they may eventually enable the
development of specific dietary interventions for translation into effective therapeutic strategies.
3.3. Altered GI Sensing in Anorexia of Ageing
Ageing, even in healthy people, is often associated with a loss of appetite, termed “anorexia of
ageing”. Older people consume smaller meals and fewer snacks, and eat more slowly, compared
with young adults [129], resulting in a decline in energy intake and weight loss. Chronic weight-loss
represents a major risk to the health and well-being of older people, hence, nutritional strategies,
which include particularly the use of protein supplements, have been developed to address this
problem [130]. While the causes of appetite loss with ageing are not completely understood, ageing is
associated with a gradual decline in metabolically active tissue, specifically muscle mass [130]; thus,
a reduction in basal metabolic rate, associated with reduced energy requirements, may lead to reduced
appetite. However, there is evidence of altered GI sensory and motor functions, including slower
gastric emptying [20], which would favour a reduction in energy intake (but also delays initiation
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of signals by nutrients in the small intestine), as well as, on the other hand, a reduced sensitivity to
the energy intake-suppressant effects of nutrients [87,88,131], and changes in the secretion of, and/or
sensitivity to, gut hormones [89]. An improved understanding of these, apparently discrepant, changes
in gastric function vs appetite signals arising from the small intestine in response to meal consumption
is likely to assist in the development of improved management strategies to ensure that older people
receive adequate nutrition.
3.3.1. Sensitivity to Gastric Distension
Older people frequently report reduced appetite before and during meal ingestion. For example,
healthy older people were less hungry before and following the ingestion of a mixed-nutrient
yogurt-based drink, and reported greater fullness after the drink than young controls [26]. Early studies
evaluated gastric emptying of meals and most [90–93], but not all [132], found that gastric emptying
of both solid and liquid meal phases was slower in older than young people, although observed
differences were often modest [91,93]. Increased gastric meal retention may enhance gastric distension
in either proximal or distal stomach contributing to fullness, as described in healthy people [23,25].
While proximal and/or distal gastric retention has been found to be greater [26,93], antral filling has also
been reported to be less [90], in older people. In response to isovolumetric or isobaric proximal gastric
distension, older people reported less fullness or bloating, and greater hunger, than young controls, at a
given volume or pressure level, in the absence of any changes in gastric compliance [94], suggesting
that healthy ageing is associated with a reduced perception of gastric distension. Reasons for the
apparent discrepancies between responses to a meal, as opposed to experimental gastric distension,
are currently unclear.
3.3.2. Alterations in the Small Intestinal Sensing of Nutrients
The effects of intestinal nutrient exposure, with a focus on protein, on GI functions and appetite in
older people have been evaluated in a limited number of studies, and findings suggest that ageing is
associated with a reduced responsiveness to the appetite-suppressant effects of nutrients [87,95,133,134].
This may be due, at least in part, to a reduced digestive capacity with ageing, since reductions in
the secretions of gastric acid, pancreatic lipase and other enzymes, as well as bile salts have been
reported [135]; however, whether these changes have any detrimental effects on the digestion of protein
and fat, and whether, or how, that may alter the GI sensing of these nutrients, requires investigation.
Response to protein: In contrast to the use of high-protein diets to achieve weight loss in
obesity [110,111], in older people protein supplements are recommended to prevent weight loss and
maintain functionality [130]. Given the potent GI and appetite-suppressant effects of protein in young
people [42,43,136], it is important to increase our knowledge of the alterations in the GI effects of
protein in older people, and underlying mechanisms. The available literature indicates that ageing is
associated with a reduced sensitivity to the satiating effect of protein [87,88,95]. For example, despite a
reduced desire to eat, as well as reduced fullness, in response to a protein drink containing either 30
g or 70 g whey protein, the suppression of energy intake relative to control from a meal consumed
180 min later was less in older people, associated with a greater cumulative intake [87]. Interestingly,
despite slower gastric emptying of the drinks in older people, energy intake from the meal was only
related to gastric emptying in the younger people [87]. Similarly, a 60-min intraduodenal infusion
of whey protein suppressed appetite and energy intake less in healthy older than in young adults,
associated with greater overall energy intake in older people [95]. Moreover, ingestion of either a whey
protein drink (70 g protein; 280 kcal), or a mixed-nutrient drink (70 g protein, 28 g carbohydrate, 12.4 g
fat; 504 kcal) did not suppress energy intake differentially, so that total energy intake was increased,
and most by the higher-energy mixed-nutrient drink [88].
Response to lipid: Only few studies have evaluated the effects of fat on appetite perception in
ageing. For example, administration of a fat emulsion (30 mL, 120 kcal) 3 times/day for six weeks
significantly increased daily energy intake by ~240 kcal [137], and either a high-fat or high-carbohydrate
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mixed-nutrient drink (250 mL, ~250 kcal) consumed after breakfast increased intake over the following
24 h by ~200 kcal [131], with no differences between fat and carbohydrate-rich drinks. One earlier
study evaluated the effects of ageing on the pyloric motor, appetite and energy intake responses to
duodenal lipid and glucose infusion [96]. Lipid stimulated pyloric pressures more in older people
(which is likely to underlie the slower gastric emptying described above), and while baseline hunger
was less in older people, and, unlike in young controls, not suppressed by either nutrient, subsequent
energy intake did not differ between the two groups.
Collectively, these studies suggest that older people are less sensitive to the appetite-suppressant
effects, but more sensitive to the inhibitory effects on the stomach, particularly gastric emptying,
of small intestinal nutrients. It is possible that these changes are due to alterations in the release of, or
sensitivity to, GI hormones.
Gut hormone responses: Available studies consistently report increased fasting plasma CCK
concentrations [89,90,97,98], as well as an exaggerated rise in response to oral or intraduodenal
nutrients [88,90,97,99], in older people. Furthermore, an inverse relationship between hunger and
plasma CCK has been found in young, but not older people [97], and exogenous administration of
CCK-8 suppressed food intake from a meal after the infusion twice as much in older, than young
people [89], suggesting that older people remain responsive to CCK and their sensitivity to the
appetite-suppressant effect of CCK may be enhanced. It is not known whether the stomach remains
sensitive to CCK with ageing; a reduced gallbladder contraction and emptying has been reported
previously [90]. Studies evaluating the secretion of GLP-1 and PYY have yielded more inconsistent
findings, with some studies reporting no differences in GLP-1 or PYY between older and young
people [97–99], or lower [45] or greater [88,90] levels in older people. It is conceivable, but has not been
investigated, that older people may be more sensitive to the effects of GLP-1 and/or PYY, resulting in
an exaggerated ileal brake effect from the distal small intestine [138]. The effects of ageing on ghrelin
secretion are also unclear, with studies reporting greater [100] or lower [101] fasting acyl-ghrelin, greater
fasting total ghrelin [98], no difference in fasting or postprandial ghrelin [102], or lower postprandial
total ghrelin [88], in older and young people.
Taken together, current evidence suggests that even healthy ageing is associated with marked
changes in upper GI functions, including delayed gastric emptying and a heightened sensitivity to
particularly CCK, both of which would favour suppression of appetite and energy intake. However,
and in apparent contrast, the appetite-suppressant effects of nutrients are reduced in older people.
While the latter lends support to the utility of dietary supplements to improve energy intake in older
people, the discrepancy between these findings and the consistently reported lack of appetite frequently
leading to undernutrition in older people requires much further research to identify mechanisms, and
other factors, that may help to explain the apparent divergence in current knowledge, with the aim to
develop improved management strategies.
4. Summary and Future Directions
This article has reviewed the sensing of meal-related signals, including both mechanical and
nutrient stimuli, in the upper GI tract, and their effects to modulate GI functions, appetite and energy
intake, in humans. The appropriate sensing of these stimuli is altered in a number of eating-related
disorders, including obesity, functional dyspepsia and anorexia of ageing, associated with compromised,
or exaggerated, responses to meals. In obesity, there is evidence of an enhanced gastric capacity
and reduced luminal sensing of gastric distension and duodenal lipid, associated with reduced
inhibition of subsequent energy intake. Functional dyspepsia, on the other hand, is associated with
hypersensitivity to both gastric distension and small intestinal lipid, amongst other food components,
which, at least in part, underlies the induction of meal-related symptoms, particularly in response to
fatty foods. Anorexia of ageing is characterised by reduced hunger perception and food intake, in
part due to delayed gastric meal emptying and an enhanced secretion of, and/or sensitivity to, gut
hormones, particularly CCK. In contrast, the satiating effects of nutrients are reduced, associated, in
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an apparent discrepancy to the free-living situation, with an increase in overall energy intake in the
laboratory setting. These examples demonstrate the existence of a variety of sensory dysfunctions
across eating-related disorders that may, at least in part, underlie the changes in food intake, or
symptoms experienced, in these conditions. Much more research is required on the cause-effect
relationships to better understand whether the sensory changes are causal, or occur as a result of
particular dietary behaviours. For example, is over-eating in obesity the result of an inherently reduced
GI sensitivity to meal-related stimuli, or does gradual over-eating lead to a desensitisation of the
sensory systems with subsequent reductions in the ability to adequately sense these stimuli? The
temporal relationship between the decline in GI sensitivity to meal-related stimuli and reduced basal
metabolic rate with ageing also warrants investigation. In functional dyspepsia, studies in large cohorts
are required to enable much more detailed investigations of the varied responses to different food
groups, and how these may relate to specific changes in small intestinal nutrient sensing. Further
technological advances will be required to investigate the alterations that occur in these disorders at
the molecular and cellular levels in vivo, and to clarify the locations of the dysregulations along both
directions of the gut-brain axis. While our knowledge in this field has advanced rapidly over the last
decade, much more work is still required in order to develop novel and effective approaches for the
management, treatment and/or prevention of these dysregulations in GI luminal sensing.
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